Which has higher earnings & valuation, MMED or DRTS?

MiniMed Group has higher revenue and earnings than Alpha Tau Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.34 N/A N/A N/A Alpha Tau Medical N/A N/A -$42.63M -$0.67 N/A

Is MMED or DRTS more profitable?

MiniMed Group's return on equity of 0.00% beat Alpha Tau Medical's return on equity. Company Net Margins Return on Equity Return on Assets MiniMed Group N/A N/A N/A Alpha Tau Medical N/A -73.23% -52.90%

Does the media favor MMED or DRTS?

In the previous week, MiniMed Group and MiniMed Group both had 9 articles in the media. Alpha Tau Medical's average media sentiment score of 0.10 beat MiniMed Group's score of 0.09 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral

Does the media prefer DRTS or WRBY?

In the previous week, Alpha Tau Medical had 6 more articles in the media than Warby Parker. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.98 beat Alpha Tau Medical's score of 0.10 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral Warby Parker 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor DRTS or TMDX?

In the previous week, Alpha Tau Medical had 6 more articles in the media than TransMedics Group. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.56 beat Alpha Tau Medical's score of 0.10 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral TransMedics Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LMAT or DRTS?

In the previous week, Alpha Tau Medical had 6 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.04 beat Alpha Tau Medical's score of 0.10 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Tau Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral

Alpha Tau Medical (DRTS) Competitors

$10.58 +1.65 (+18.48%)

Closing price 06/3/2026 04:00 PM Eastern

Extended Trading

$10.44 -0.14 (-1.36%)

As of 06/3/2026 08:00 PM Eastern

Compare

DRTS vs. MMED, SLNO, WRBY, TMDX, and LMAT

Should you buy Alpha Tau Medical stock or one of its competitors? MarketBeat compares Alpha Tau Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Tau Medical include MiniMed Group (MMED), Soleno Therapeutics (SLNO), Warby Parker (WRBY), TransMedics Group (TMDX), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

How does Alpha Tau Medical compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Alpha Tau Medical (NASDAQ:DRTS) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

MiniMed Group's return on equity of 0.00% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Alpha Tau Medical	N/A	-73.23%	-52.90%

19.7% of MiniMed Group shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 2.2% of MiniMed Group shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

MiniMed Group has higher revenue and earnings than Alpha Tau Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

In the previous week, MiniMed Group and MiniMed Group both had 9 articles in the media. Alpha Tau Medical's average media sentiment score of 0.10 beat MiniMed Group's score of 0.09 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral

MiniMed Group presently has a consensus target price of $21.67, indicating a potential upside of 51.94%. Alpha Tau Medical has a consensus target price of $12.20, indicating a potential upside of 15.31%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities analysts clearly believe MiniMed Group is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.80
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

MiniMed Group beats Alpha Tau Medical on 8 of the 10 factors compared between the two stocks.

How does Alpha Tau Medical compare to Soleno Therapeutics?

Soleno Therapeutics (NASDAQ:SLNO) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership.

In the previous week, Alpha Tau Medical had 8 more articles in the media than Soleno Therapeutics. MarketBeat recorded 9 mentions for Alpha Tau Medical and 1 mentions for Soleno Therapeutics. Soleno Therapeutics' average media sentiment score of 0.94 beat Alpha Tau Medical's score of 0.10 indicating that Soleno Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Soleno Therapeutics	Positive
Alpha Tau Medical	Neutral

Soleno Therapeutics currently has a consensus price target of $76.67, indicating a potential upside of 44.63%. Alpha Tau Medical has a consensus price target of $12.20, indicating a potential upside of 15.31%. Given Soleno Therapeutics' higher probable upside, equities research analysts clearly believe Soleno Therapeutics is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Soleno Therapeutics	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Soleno Therapeutics has a net margin of 33.70% compared to Alpha Tau Medical's net margin of 0.00%. Soleno Therapeutics' return on equity of 22.85% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Soleno Therapeutics	33.70%	22.85%	18.25%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Soleno Therapeutics has a beta of -2.22, suggesting that its stock price is 322% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

Soleno Therapeutics has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Soleno Therapeutics	$285.01M	9.69	$20.89M	$1.77	29.95
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

97.4% of Soleno Therapeutics shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 6.4% of Soleno Therapeutics shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Soleno Therapeutics beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Warby Parker?

Alpha Tau Medical (NASDAQ:DRTS) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

In the previous week, Alpha Tau Medical had 6 more articles in the media than Warby Parker. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.98 beat Alpha Tau Medical's score of 0.10 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral
Warby Parker	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 16.8% of Warby Parker shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Warby Parker has a net margin of 0.15% compared to Alpha Tau Medical's net margin of 0.00%. Warby Parker's return on equity of 2.30% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-73.23%	-52.90%
Warby Parker	0.15%	2.30%	1.18%

Alpha Tau Medical has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.96, suggesting that its stock price is 96% more volatile than the broader market.

Alpha Tau Medical presently has a consensus price target of $12.20, suggesting a potential upside of 15.31%. Warby Parker has a consensus price target of $29.50, suggesting a potential upside of 21.42%. Given Warby Parker's stronger consensus rating and higher probable upside, analysts plainly believe Warby Parker is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.64

Warby Parker has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A
Warby Parker	$871.91M	2.98	$1.64M	$0.02	1,214.75

Summary

Warby Parker beats Alpha Tau Medical on 13 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to TransMedics Group?

Alpha Tau Medical (NASDAQ:DRTS) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.

In the previous week, Alpha Tau Medical had 6 more articles in the media than TransMedics Group. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.56 beat Alpha Tau Medical's score of 0.10 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral
TransMedics Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Tau Medical currently has a consensus target price of $12.20, suggesting a potential upside of 15.31%. TransMedics Group has a consensus target price of $134.00, suggesting a potential upside of 92.28%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts clearly believe TransMedics Group is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

TransMedics Group has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A
TransMedics Group	$605.49M	3.98	$190.29M	$4.40	15.84

TransMedics Group has a net margin of 27.04% compared to Alpha Tau Medical's net margin of 0.00%. TransMedics Group's return on equity of 22.38% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-73.23%	-52.90%
TransMedics Group	27.04%	22.38%	8.46%

Alpha Tau Medical has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.91, suggesting that its share price is 91% more volatile than the broader market.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

TransMedics Group beats Alpha Tau Medical on 13 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

LeMaitre Vascular has a net margin of 24.35% compared to Alpha Tau Medical's net margin of 0.00%. LeMaitre Vascular's return on equity of 15.36% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
Alpha Tau Medical	N/A	-73.23%	-52.90%

LeMaitre Vascular has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	8.39	$57.73M	$2.71	33.82
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

LeMaitre Vascular currently has a consensus price target of $112.60, suggesting a potential upside of 22.87%. Alpha Tau Medical has a consensus price target of $12.20, suggesting a potential upside of 15.31%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, research analysts plainly believe LeMaitre Vascular is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Alpha Tau Medical had 6 more articles in the media than LeMaitre Vascular. MarketBeat recorded 9 mentions for Alpha Tau Medical and 3 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.04 beat Alpha Tau Medical's score of 0.10 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Tau Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Neutral

LeMaitre Vascular has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

Summary

LeMaitre Vascular beats Alpha Tau Medical on 12 of the 15 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DRTS vs. The Competition

Export

Metric	Alpha Tau Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$806.61M	$7.25B	$6.47B	$12.54B
Dividend Yield	N/A	1.23%	2.69%	5.22%
P/E Ratio	-15.79	45.06	22.39	24.18
Price / Sales	N/A	74.02	520.79	112.26
Price / Cash	N/A	24.22	41.34	57.13
Price / Book	12.02	7.15	9.84	6.72
Net Income	-$42.63M	$159.22M	$3.57B	$337.19M
7 Day Performance	4.44%	-2.00%	-2.46%	-0.74%
1 Month Performance	N/A	N/A	N/A	-1.69%
1 Year Performance	259.86%	0.95%	26.49%	33.10%

Alpha Tau Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DRTS Alpha Tau Medical	2.4831 of 5 stars	$10.58 +18.5%	$12.20 +15.3%	+252.7%	$806.61M	N/A	N/A	80	News Coverage Analyst Forecast Options Volume Gap Up High Trading Volume
MMED MiniMed Group	3.6645 of 5 stars	$11.18 -5.8%	$21.67 +93.8%	N/A	$3.14B	$2.99B	N/A	8,000	News Coverage Earnings Report Options Volume Gap Up
SLNO Soleno Therapeutics	4.2871 of 5 stars	$53.01 flat	$76.67 +44.6%	N/A	$2.76B	$285.01M	29.95	30
WRBY Warby Parker	4.0922 of 5 stars	$25.56 +1.9%	$29.50 +15.4%	+16.9%	$2.69B	$871.91M	1,278.64	4,036
TMDX TransMedics Group	4.6024 of 5 stars	$70.46 +2.2%	$134.00 +90.2%	-45.9%	$2.38B	$605.49M	16.01	210

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DRTS) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Tau Medical (DRTS) Competitors

DRTS vs. MMED, SLNO, WRBY, TMDX, and LMAT

How does Alpha Tau Medical compare to MiniMed Group?

Summary

How does Alpha Tau Medical compare to Soleno Therapeutics?

Summary

How does Alpha Tau Medical compare to Warby Parker?

Summary

How does Alpha Tau Medical compare to TransMedics Group?

Summary

How does Alpha Tau Medical compare to LeMaitre Vascular?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRTS vs. The Competition

Alpha Tau Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Tau Medical (DRTS) Competitors

DRTS vs. MMED, SLNO, WRBY, TMDX, and LMAT

How does Alpha Tau Medical compare to MiniMed Group?

Is MMED or DRTS more profitable?

Do institutionals & insiders believe in MMED or DRTS?

Which has higher earnings & valuation, MMED or DRTS?

Does the media favor MMED or DRTS?

Do analysts rate MMED or DRTS?

Summary

How does Alpha Tau Medical compare to Soleno Therapeutics?

Does the media refer more to SLNO or DRTS?

Do analysts rate SLNO or DRTS?

Is SLNO or DRTS more profitable?

Which has more volatility and risk, SLNO or DRTS?

Which has preferable valuation & earnings, SLNO or DRTS?

Do institutionals and insiders believe in SLNO or DRTS?

Summary

How does Alpha Tau Medical compare to Warby Parker?

Does the media prefer DRTS or WRBY?

Do institutionals & insiders hold more shares of DRTS or WRBY?

Is DRTS or WRBY more profitable?

Which has more volatility and risk, DRTS or WRBY?

Do analysts prefer DRTS or WRBY?

Which has better valuation and earnings, DRTS or WRBY?

Summary

How does Alpha Tau Medical compare to TransMedics Group?

Does the media favor DRTS or TMDX?

Do analysts prefer DRTS or TMDX?

Which has higher earnings & valuation, DRTS or TMDX?

Is DRTS or TMDX more profitable?

Which has more risk & volatility, DRTS or TMDX?

Do institutionals and insiders hold more shares of DRTS or TMDX?

Summary

How does Alpha Tau Medical compare to LeMaitre Vascular?

Is LMAT or DRTS more profitable?

Which has stronger earnings & valuation, LMAT or DRTS?

Do insiders and institutionals believe in LMAT or DRTS?

Do analysts recommend LMAT or DRTS?

Does the media refer more to LMAT or DRTS?

Which has more risk & volatility, LMAT or DRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRTS vs. The Competition

Alpha Tau Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools